You are here
ANTIOP, INC.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Naloxone Nasal Spray Development
Amount: $2,986,389.00DESCRIPTION: The following proposal is a follow-on Phase 2 b application from our initial proposal (1-R42 DA 030001). U.S. drug overdose deaths, mostly commonly from opioids, now exceed deaths from a ...
STTRPhase II2013Department of Health and Human Services National Institutes of Health -
Intranasal Naloxone: An Opioid Overdose Antidote
Amount: $1,219,884.00DESCRIPTION (provided by applicant): There is a significant unmet medical need to provide additional pharmacologic treatments for treatment and prevention of opioid overdose. This Fast Track STTR proj ...
STTRPhase II2011Department of Health and Human Services National Institutes of Health -
Intranasal Naloxone: An Opioid Overdose Antidote
Amount: $239,908.00DESCRIPTION (provided by applicant): There is a significant unmet medical need to provide additional pharmacologic treatments for treatment and prevention of opioid overdose. This Fast Track STTR proj ...
STTRPhase I2010Department of Health and Human Services National Institutes of Health